Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds

Details for Australian Patent Application No. 2002254999 (hide)

Owner Switch Biotech AG

Inventors Goppelt, Andreas; Hof, Peter; Halle, Jorn-Peter

Agent Watermark

Pub. Number AU-B-2002254999

PCT Pub. Number WO2002/088180

Priority 101 21 255.0 30.04.01 DE; 60/323,348 18.09.01 US

Filing date 30 April 2002

Wipo publication date 11 November 2002

Acceptance publication date 26 July 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 35/36 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Skin

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C07K 16/38 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against protease inhibitors of peptide structure

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002254999

26 July 2007 Application Accepted

  Published as AU-B-2002254999

22 November 2007 Standard Patent Sealed

23 June 2011 Assignment Registered

  Switch Biotech AG The patent has been assigned to Bayer Innovation GmbH

2 February 2012 Assignment Registered

  Bayer Innovation GmbH The patent has been assigned to Bayer Innovation GmbH; Ludwig-Maximilians-Universitaet Muenchen

23 February 2012 Assignment Registered

  Ludwig-Maximilians-Universitaet Muenchen; Bayer Innovation GmbH The patent has been assigned to Bayer Innovation GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002255000-SYSTEM, APPARATUS AND METHOD FOR SIM-BASED AUTHENTICATION AND ENCRYPTION IN WIRELESS LOCAL AREA NETWORK ACCESS

2002254998-COOLING ELEMENT FOR COOLING THE WALLS OF SHAFT FURNACES